Veterinary Quarterly,
Journal Year:
2024,
Volume and Issue:
44(1), P. 1 - 23
Published: July 7, 2024
Mastitis
is
an
inflammatory
condition
that
affects
dairy
cow's
mammary
glands.
Traditional
treatment
approaches
with
antibiotics
are
increasingly
leading
to
challenging
scenarios
such
as
antimicrobial
resistance.
In
order
mitigate
the
unwanted
side
effects
of
antibiotics,
alternative
strategies
those
harness
host
immune
system
response,
also
known
immunotherapy,
have
been
implemented.
Immunotherapy
treat
bovine
mastitis
aims
enhance
response
against
pathogens
by
promoting
pathogen
clearance,
and
facilitating
tissue
repair.
Various
studies
demonstrated
potential
immunotherapy
for
reducing
incidence,
duration
severity
mastitis.
Nevertheless,
majority
reported
therapies
lacking
in
specificity
hampering
their
broad
application
Meanwhile,
advancements
hold
great
promise
industry,
provide
effective
sustainable
alternatives
traditional
antibiotic-based
approaches.
This
review
synthesizes
strategies,
current
understanding
future
perspectives.
The
perspectives
should
focus
on
development
precision
immunotherapies
tailored
address
individual
pathogens/group
pathogens,
combination
resistance,
integration
nano-
omics
technologies.
By
addressing
research
gaps,
field
can
make
significant
strides
control,
prevention
mastitis,
ultimately
benefiting
both
animal
human
health/welfare,
environment
health.
Abstract
Post‐transcriptional
mRNA
modifications
play
diverse
roles
in
gene
expression
and
RNA
function.
In
many
cases,
function
by
altering
how
cellular
machinery
such
as
binding
proteins
(RBPs)
interact
with
substrates.
For
instance,
N6‐methyladenosine
(m6A)
is
recognized
the
well‐characterized
YTH
domain‐containing
family
of
“reader”
proteins.
other
modifications,
similar
global
readers
modification
status
have
not
been
clearly
defined.
Rather,
most
interactions
between
RBPs
a
more
complicated
dependence
on
sequence
context
modality.
The
current
handful
studies
that
demonstrate
impacting
protein
likely
represent
only
fraction
full
landscape.
this
review,
we
dissect
known
instances
RBP
binding,
specifically
m6A,
N1‐methyladenosine
(m1A),
5‐methylcytosine
(m5C),
pseudouridine
(Ψ),
internal
N7‐methylguanosine.
We
then
review
biochemical
properties
these
identified
including
dihydrouridine
(D),
N4
‐
acetylcytosine
(ac4C),
2′‐O‐Methylation
(Nme).
focus
would
be
to
impact
RNA:RBP
interactions,
changes
hydrogen
bond
potential,
base‐stacking
efficiency,
conformational
preferences.
effects
secondary
structure
well‐studied,
briefly
discuss
structural
imparted
can
lead
changes.
Finally,
strategies
for
uncovering
as‐yet‐to‐be
modification‐sensitive
RBP:RNA
Interactions.
Coordinating
future
efforts
intersect
epitranscriptome
RNA–protein
interactome
will
illuminate
rules
governing
recognition
mechanisms
responsible
biological
consequences
modification.
This
article
categorized
under:
Structure
Dynamics
>
Structure,
Chemistry
Interactions
Proteins
Other
Molecules
Protein‐RNA
Recognition
Processing
Editing
Modification
Angewandte Chemie International Edition,
Journal Year:
2024,
Volume and Issue:
63(22)
Published: March 26, 2024
Ribonucleic
acids
(RNAs)
play
a
vital
role
in
living
organisms.
Many
of
their
cellular
functions
depend
critically
on
chemical
modification.
Methods
to
modify
RNA
controlled
manner-both
vitro
and
vivo-are
thus
essential
evaluate
understand
biology
at
the
molecular
mechanistic
levels.
The
diversity
modifications,
combined
with
size
uniformity
(made
up
only
4
nucleotides)
makes
its
site-specific
modification
challenging
task
that
needs
be
addressed
by
complementary
approaches.
One
such
approach
is
solid-phase
synthesis.
We
discuss
recent
developments
this
field,
starting
new
protection
concepts
ongoing
effort
overcome
current
limitations.
continue
selected
modifications
have
posed
significant
challenges
for
incorporation
into
RNA.
These
include
deazapurine
bases
required
atomic
mutagenesis
elucidate
aspects
catalytic
RNAs,
containing
xanthosine,
N
Journal of Translational Medicine,
Journal Year:
2025,
Volume and Issue:
23(1)
Published: Jan. 6, 2025
Immuno-oncology
has
witnessed
remarkable
advancements
in
the
past
decade,
revolutionizing
landscape
of
cancer
therapeutics
an
encouraging
manner.
Among
diverse
immunotherapy
strategies,
mRNA
vaccines
have
ushered
a
new
era
for
therapeutic
management
malignant
diseases,
primarily
due
to
their
impressive
impact
on
COVID-19
pandemic.
In
this
comprehensive
review,
we
offer
systematic
overview
vaccines,
focusing
optimization
structural
design,
crucial
role
delivery
materials,
and
administration
route.
Additionally,
summarize
preclinical
studies
clinical
trials
provide
valuable
insights
into
current
status
treatment.
Furthermore,
delve
discussion
significant
challenges
facing
development
tumor
vaccines.
These
encompass
both
intrinsic
external
factors
that
are
closely
intertwined
with
successful
application
innovative
approach.
To
pave
way
more
promising
future
treatments,
deeper
understanding
immunological
mechanisms,
increasing
number
high-quality
trials,
well-established
manufacturing
platform
crucial.
Collaborative
efforts
between
scientists,
clinicians,
industry
engineers
essential
achieving
these
goals.
Theranostics,
Journal Year:
2025,
Volume and Issue:
15(6), P. 2428 - 2450
Published: Jan. 20, 2025
Rationale:
Abnormal
metabolic
states
contribute
to
a
variety
of
diseases,
including
cancer.
RNA
modifications
have
diverse
biological
functions
and
are
implicated
in
cancer
development,
gastric
(GC).
However,
the
direct
relationship
between
glucose
homeostasis
4-acetylcytosine
(ac4C)
modification
GC
remains
unclear.
Methods:
The
prognostic
value
acetyltransferase
NAT10
expression
was
evaluated
human
cohort.
Additionally,
preoperative
PET/CT
data
from
patients
Micro-PET/CT
imaging
mice
were
employed
assess
metabolism.
role
investigated
through
various
experiments,
xenografts,
organoids,
conditional
knockout
(cKO)
mouse
model.
underlying
mechanisms
examined
using
dot
blotting,
immunofluorescence
staining,
co-immunoprecipitation,
high-throughput
sequencing,
among
other
techniques.
Results:
Glucose
deprivation
activates
autophagy-lysosome
pathway,
leading
degradation
by
enhancing
its
interaction
with
sequestosome
1
(SQSTM1)/microtubule-associated
protein
light
chain
3
alpha
(LC3)
complex,
ultimately
resulting
reduction
ac4C
modification.
Furthermore,
levels
elevated
tissues
correlate
poor
prognosis.
A
strong
correlation
exists
18F-FDG
uptake
patients.
drives
glycolytic
metabolism
carcinogenesis
vitro
vivo.
Mechanistically,
stimulates
at
intersection
coding
sequence
(CDS)
3'
untranslated
region
(3'UTR)
hexokinase
2
(HK2)
mRNA,
stability
activating
thereby
driving
tumorigenesis.
Conclusion:
Our
findings
highlight
critical
crosstalk
epitranscriptome
carcinogenesis.
This
finding
offers
potential
strategy
targeting
NAT10/HK2
axis
for
treatment
patients,
especially
those
highly
active
Chemical Society Reviews,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 1, 2025
The
deep
interconnection
between
nucleic
acids
and
carbohydrates
has
prompted
numerous
synthetic
campaigns
to
understand
acid
etiology,
develop
orthogonal
genetic
systems,
improve
the
properties
of
therapeutic
oligonucleotides.
Advanced Science,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 22, 2025
Abstract
The
relationship
between
patterns
of
RNA
modifications
and
gastric
cancer
(GC)
liver
metastasis
(GCLM)
remains
unclear.
Here,
by
single‐cell
sequencing,
clinical
sample
analysis,
mouse
model
studies,
an
abnormal
increase
in
the
expression
acetyltransferase
N‐acetyltransferase
10
(NAT10)
metastatic
GC
cells
is
identified.
NAT10‐mediated
N4‐acetylcytidine
modification
CXCL2
KLF5
mRNA
increases
their
stability.
Then,
secreted
found
to
promote
infiltration
polarization
M2‐like
macrophages
produce
oncostatin
M,
which
transcriptionally
activates
NAT10
via
STAT3
signaling.
In
addition,
organoid
models
confirm
that
promotes
adhesion
hepatocytes.
Mechanistically,
ITGαV,
facilitating
cell
attachment
Intriguingly,
high
NAT10/KLF5
axis
associated
with
poor
prognosis
patients
targeting
this
significantly
reduces
GCLM
preclinical
murine
models.
Collectively,
these
findings
suggest
significance
developing
targeted
therapies
for
metastasis.
Journal of Translational Medicine,
Journal Year:
2025,
Volume and Issue:
23(1)
Published: Feb. 28, 2025
M6A
modification
is
one
of
the
most
common
regulatory
mechanisms
gene
expression
in
eukaryotic
cells,
influencing
processes
such
as
RNA
splicing,
degradation,
stability,
and
protein
translation.
Studies
have
shown
that
m6A
methylation
closely
associated
with
tumorigenesis
progression,
it
plays
a
key
role
tumor
immune
responses.
participates
regulating
differentiation
maturation
well
related
anti-tumor
In
microenvironment,
can
also
affect
cell
recruitment,
activation,
polarization,
thereby
promoting
or
inhibiting
proliferation
metastasis,
reshaping
microenvironment.
recent
years,
immunotherapies
for
tumors,
checkpoint
inhibitors
adoptive
immunotherapy,
been
increasingly
applied
clinical
settings,
achieving
favorable
outcomes.
Targeting
modifications
to
modulate
system,
using
small-molecule
target
dysregulated
factors
inducing
reprogramming,
enhance
responses
strengthen
recognition
cytotoxicity
against
cells.
represents
new
direction
immunotherapy
promising
potential.
This
review
discusses
on
cells
explores
strategies
immunotherapy.